Genetics & Longevity Blueprint

Advanced genetic screening panel mapping inherited risks, aging predispositions, and medication response to guide lifelong preventive and longevity planning.

CHF450.00
35 Biomarkers
0 Health Domains
48h Results
ISO 15189 Certified
Genetics & Longevity Blueprint

What This Measures

BRCA1/2 Gene Sequencing

Analyzes tumor-suppressor genes to identify inherited mutations that increase risk for breast, ovarian, pancreatic, and prostate cancers.

Longevity SNP Panel

Examines key SNPs linked to lifespan, metabolic efficiency, cellular repair mechanisms, and age-related health conditions to define your inherited baseline for healthy aging.

Pharmacogenomics (PGx)

Evaluates how your genetic makeup influences medication response, identifying fast/slow metabolism patterns, potential toxicities, or reduced efficacy.

Why It's Important

  • Your genetic code influences how you respond to the environment, process medications, and handle cellular damage over time.
  • This panel helps identify inherited risk factors for aggressive cancers.
  • It can reveal predispositions toward accelerated cellular aging or inflammation.
  • It can surface variations in how your body handles fats, vitamins, and metabolic stress.
  • It can flag potential adverse drug reactions or ineffective medications before use.
  • It provides foundational, unchanging data to guide lifelong medical decisions.

Potential Benefits

  • Lifetime visibility into high-priority inherited health and cancer risks.
  • Opportunity for targeted early surveillance and prevention strategies.
  • Reduced trial-and-error prescribing through personalized medication profiling.
  • Support for gene-guided lifestyle, diet, and supplement adjustments.
  • Peace of mind through actionable, long-term preventive insight.

Who May Benefit Most

  • Individuals with a strong family history of cancer, early heart disease, or chronic conditions.
  • People who want to optimize long-term health span based on their genetic blueprint.
  • Those who take or may need prescription medications and want to avoid adverse effects.
  • People focused on advanced longevity strategies and customized wellness protocols.
  • Anyone seeking a one-time foundational test to guide decades of healthcare decisions.

Important to Know

  • This is a predictive genetic risk assessment; having a variant does not guarantee disease development.
  • Genetic results are best reviewed with a medical professional or certified genetic counselor.
  • Pharmacogenomic data should only guide medication changes under physician supervision.

Conditions Addressed:

Inherited cancer risk factors
Accelerated cellular aging or inflammation predisposition
Metabolic stress and nutrient processing variations
Potential adverse drug reactions or ineffective medications
Foundational genetic drivers of long-term health
CHF450.00